A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy

Condition:   Anemia Interventions:   Drug: Darbepoetin alfa;   Drug: Placebo Sponsor:   Amgen Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials